 Are smart delivery systems the solution to overcome the lack of selectivity of current metallodrugs in cancer therapy? |  Emerging molecular receptors for the specific-target delivery of ruthenium and gold complexes into cancer cells |  Novel “ruthenium cyclopentadienyl”–peptide conjugate complexes against human FGFR(+) breast cancer |
---|